Multiscale classification of heart failure phenotypes by unsupervised clustering of unstructured electronic medical

Tasha Nagamine1, Brian Gillette2,3, Alexey Pakhomov1

  • 1Droice Research, New York, NY, USA.

Scientific Reports
|December 8, 2020
PubMed

Insights

This study introduces a novel data-driven method to subgroup heart failure (HF) patients using clinical notes. This approach reveals distinct HF patient profiles for better understanding and treatment.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Computational Biology

Background:

  • Heart failure (HF) is a major cause of death and healthcare costs globally.
  • Current HF subtyping methods lack precision due to diverse patient factors, limiting clinical decisions and therapy development.
  • A data-driven approach is needed to better characterize real-world HF patient heterogeneity.

Purpose of the Study:

  • To develop and validate a novel, data-driven methodology for characterizing heart failure patient subpopulations.
  • To leverage natural language processing (NLP) and clustering on electronic health record (EHR) data to identify distinct HF patient groups.
  • To uncover clinically interpretable subgroups based on patient complaints and manifestations.

Main Methods:

  • Utilized NLP to process unstructured clinical notes from EHRs, extracting disease and symptom concepts (complaints).
  • Constructed vectorized representations of patient complaints.
  • Applied clustering algorithms to group HF patients based on complaint vector similarity and identified enriched complaints within each cluster via statistical testing.

Main Results:

  • Successfully clustered heart failure patients into clinically interpretable subgroups based on complaint patterns.
  • Identified known HF etiologies, risk factors, and comorbidities (e.g., ischemic heart disease, hypertension, diabetes) within the discovered subgroups.
  • Provided deeper insights into the specific clinical manifestations of HF within each identified subgroup.

Conclusions:

  • The novel NLP and clustering approach effectively characterizes real-world heart failure patient heterogeneity.
  • This hypothesis-free methodology can reveal clinically meaningful HF subgroups and inform personalized treatment strategies.
  • The approach is adaptable for discovering novel insights in other diseases and patient populations.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
146
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.2K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
301
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
330
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
176
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
178